Global Patient Blood Management Market Size Study & Forecast, by Product (Instrument, Accessories, Reagents, Software) and End User (Blood Bank, Hospital) and Regional Forecasts 2025-2035

Global Patient Blood Management Market is valued approximately at USD 15.3 billion in 2024 and is anticipated to expand at a CAGR of 7.40% over the forecast period 2025-2035. Patient Blood Management (PBM) encompasses a multidisciplinary approach aimed at optimizing the care of patients who might require transfusion, integrating advanced diagnostic techniques, blood conservation strategies, and innovative technologies to ensure improved patient outcomes. The market growth is propelled by increasing prevalence of chronic diseases, rising surgical procedures, and heightened awareness regarding blood safety and management protocols. Additionally, the adoption of technologically advanced instruments and software solutions for monitoring, storage, and transfusion is catalyzing market expansion.

The accelerating demand for efficient blood management solutions is primarily driven by the surging number of surgical interventions, growing incidence of anemia, and the need to minimize transfusion-related complications. Instruments such as centrifuges, apheresis devices, transfusion devices, and advanced storage equipment are increasingly being deployed to enhance patient outcomes and operational efficiency. Moreover, healthcare institutions are integrating software solutions for blood inventory management and predictive analytics, enabling real-time monitoring and optimized utilization of blood products. The advent of next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies is further broadening market potential, offering precise diagnostics and tailored therapeutic interventions. Nevertheless, high costs associated with advanced PBM systems and stringent regulatory compliance may pose challenges to market growth.

Regionally, North America holds a commanding share of the Global Patient Blood Management Market, owing to the presence of advanced healthcare infrastructure, extensive adoption of cutting-edge medical technologies, and a robust network of hospitals and blood banks. Europe follows closely, driven by rising awareness programs, government initiatives promoting safe transfusion practices, and the prevalence of sophisticated diagnostic instruments. Asia Pacific is expected to witness the fastest growth throughout the forecast period, fueled by expanding healthcare infrastructure, increasing surgical volumes, and rising investments in medical technologies across China, India, Japan, and Australia. Latin America and the Middle East & Africa are anticipated to present lucrative opportunities due to growing healthcare expenditures and improving blood management practices.

Major market players included in this report are:
• Fresenius Kabi AG
• Terumo Corporation
• Haemonetics Corporation
• Grifols, S.A.
• Macopharma SA
• Bio-Rad Laboratories, Inc.
• Cerus Corporation
• Miltenyi Biotec
• Baxter International Inc.
• Becton, Dickinson and Company
• Danaher Corporation
• Siemens Healthineers
• Roche Diagnostics
• GE Healthcare
• Luminex Corporation

Global Patient Blood Management Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device)
• Accessories (Syringes, Vials)
• Reagents
• Software

By End User:
• Blood Bank
• Hospital

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• RoE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• RoMEA

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more